Seurat Therapeutics, Inc.
Biotechnology company · Chicago, Illinois, United States
Seurat Therapeutics, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2016. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $509,720 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $773,487 sold in a notice filed in 2018.
Seurat Therapeutics at a glance
What does Seurat Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $509,720 in total (2018). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $773,487 sold (2018).
Frequently asked questions about Seurat Therapeutics
Where is Seurat Therapeutics headquartered?
Seurat Therapeutics, Inc. is headquartered in Chicago, Illinois, United States.
What does Seurat Therapeutics do?
Seurat Therapeutics, Inc. is a biotechnology company.
When was Seurat Therapeutics founded?
The earliest incorporation on record for Seurat Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Metame Health Inc.Chicago, Illinois, United States
- Synapticure, Inc.Chicago, Illinois, United States
- BiomeSense, Inc.Chicago, Illinois, United States
- Inomagen Therapeutics, Inc.Chicago, Illinois, United States
- Nuago Therapeutics, Inc.Chicago, Illinois, United States
- Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
- Diagnostic Photonics, Inc.Chicago, Illinois, United States
- Microsensor Labs, LLCChicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences